Ashraf, Muhammad W. http://orcid.org/0000-0002-9947-1579
Uusalo, Panu http://orcid.org/0000-0001-5120-8854
Scheinin, Mika http://orcid.org/0000-0001-7579-9126
Saari, Teijo I. http://orcid.org/0000-0003-1225-4561
Funding for this research was provided by:
Turun Yliopistollinen Keskussairaala (13821)
Turun Yliopisto
Article History
First Online: 27 May 2020
Compliance with Ethical Standards
:
: MWA, PU and TIS received a speaker honorarium from Orion Pharma Ltd (Espoo, Finland). MS had contract research relationships with Orion Corporation Ltd (Espoo, Finland), Novartis Pharma (Espoo, Finland), Desentum Ltd (Helsinki, Finland), Gabather AB (Gothenburg, Sweden), AbbVie AG (Germany) and AC Immune SA (Lausanne, Switzerland). In addition, MS has received fees for participation on Data and Safety Committees in Faron Pharmaceuticals (Turku, Finland) and Herantis Pharma (Helsinki, Finland). MS has received a speaker’s fee from Pharma Industry Finland (Helsinki, Finland) and he has stock options for Santhera Pharmaceuticals (Pratteln, Switzerland).